Tag: Rivaroxaban

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events

Coronary/Structural Heart by 0 comments

Pivotal UNIVERSE study published in the Journal of the American Heart Association Data included in recent New Drug Application submitted to FDA for two pediatric indications RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today […]

Continue Reading →